Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
All subjects will be randomized as Alo/Pio combo group (intervention) or Glim/Met combo group (control) after intensive COAD treatment based on identical protocol. * All subject will be managed with once daily, fixed dose, single tablet treatment based on the study protocol, and followed-up for 104 weeks. * Any group of subjects who fail to reach glycemic target with single tablet treatment, subject will be treated with rescue medication and stopped regular observation.
Epistemonikos ID: c9067d6b216c172b720ba9f120525cbae05de124
First added on: May 17, 2024